BCTX

Briacell Therapeutics Corp. Common Shares

7.25

USD

BCTX Earnings Reports

Positive Surprise Ratio

BCTX beat 7 of 15 last estimates.

47%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q2 26 (Revenue/ EPS)

-$4.88

Implied change from Q1 26 (Revenue/ EPS)

Implied change from Q2 25 (Revenue/ EPS)

-79.06%

Briacell Therapeutics Corp. Common Shares earnings per share and revenue

On Dec 15, 2025, BCTX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -3.31 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.12 million, with a --% difference.

Looking ahead to Q2 26, 2 analysts forecast an EPS of -4.88 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Briacell Therapeutics Corp. Common Shares's earnings and revenue for the latest quarter Q1 2026?

For Q1 2026, Briacell Therapeutics Corp. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Briacell Therapeutics Corp. Common Shares's Q1 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Briacell Therapeutics Corp. Common Shares expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for Briacell Therapeutics Corp. Common Shares's next earnings report?

Based on 2 analysts, Briacell Therapeutics Corp. Common Shares is expected to report EPS of -$4.88 and revenue of -- for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.